Abstract
We consider a dynamical model of cancer growth including three interacting cell populations of tumor cells, healthy host cells and immune effector cells. The tumor–immune and the tumor–host interactions are characterized to reproduce experimental results. A thorough dynamical analysis of the model is carried out, showing its capability to explain theoretical and empirical knowledge about tumor development. A chemotherapy treatment reproducing different experiments is also introduced. We believe that this simple model can serve as a foundation for the development of more complicated and specific cancer models.
Similar content being viewed by others
References
Bellomo N, Li NK, Maini PK (2008) On the foundations of cancer modelling: selected topics, speculations, and perspectives. Math Models Methods Appl Sci 18:593–646
Couzin-Frankel J (2013) Cancer immunotherapy. Science 342:1432–1433
De Pillis LG, Radunskaya A (2003) The dynamics of an optimally controlled tumor model: a case study. Math Comput Model 37:1221–1244
De Pillis LG, Radunskaya AE, Wiseman CL (2005) A validated mathematical model of cell-mediated immune response to tumor growth. Cancer Res 65:235–252
De Pillis LG, Gu W, Radunskaya AE (2006) Mixed immunotherapy and chemotherapy of tumors: modelling, applications and biological interpretations. J Theor Biol 238:841–862
Diefenbach A, Jensen ER, Jamieson AM, Rauelt DG (2001) Rae1 and H60 ligands of the NKG2D receptor stimulate tumor immunity. Nature 413:165–171
Dudley ME, Wunderlich JR, Robbins PF, Yang JC, Hwu P, Schwartzentruber DJ, Topalian SL, Sherry R, Restifo NP, Hubicki AM, Robinson MR, Raffeld M, Duray P, Seipp CA, Rogers-Freezer L, Morton KE, Mavroukakis SA, White DE, Rosenberg SA (2002) Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science 298:850854
Ferreira SC Jr, Martins ML, Vilela MJ (2002) Reaction-diffusion model for the growth of avascular tumor. Phys Rev E 67:051914
Gardner SN (1996) A mechanistic, predictive model of dose-response curves for cell cycle phase-specific and nonspecific drugs. Cancer Res 60:1417–1425
Gardner SM (2002) Modeling multi-drug chemotherapy: tailoring treatment to individuals. J Theor Biol 214:181–207
Gatenby RA, Gawlinsky ET (1996) A reaction–diffusion model of cancer invasion. Cancer Res 56:5475–5753
Hanahan D, Weinberg RA (2000) Hallmarks of cancer. Cell 100:5770
Hiramoto RN, Ghanta VK (1974) Chemotherapy and rate of kill of tumor cells in a mouse plasmacytome. Cancer Res 34:1738–1742
Ideta AM, Tanaka G, Takeuchi T, Aihara K (2008) A mathematical model of intermittent androgen suppression for prostate cancer. J Nonlinear Sci 18:593–614
Kirschner D, Panetta JC (1988) Modelling immunotherapy of the tumor–immune interaction. J Math Biol 37:235–252
Kuznetsov VA, Makalkin IA, Taylor MA, Perelson AS (1994) Nonlinear dynamics of immunogenic tumors: parameter estimation and global bifurcation analysis. Bull Math Biol 56:295321
Lavi O, Gottesman MM, Levy D (2012) The dynamics of drug resistance: a mathematical perspective. Drug Resist Updat 15:90–97
Mallet DG, De Pillis LG (2006) A cellular automata model of tumor–immune system interactions. J Theor Biol 239:334–350
Nowak MA (1992) What is quasispecies? Trends Ecol Evol 7:118–121
Olumi AF, Gary DG, Hayward SW, Carrol PR, Tlsty RD, Cunha GR (1999) Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res 59:5002–5011
Panetta JC, Adam J (1995) A mathematical model of cycle-specific chemotherapy. Math Comput Model 22:67–82
Pastorino F, Brignole C, Di Paolo D, Nico B, Pezzolo A, Marimpietri D, Pagnan G, Piccardi F, Cilli M, Longhi R, Ribatti D, Corti A, Allen MT, Ponzoni M (2006) Targeting liposomal chemotherapy via both tumor cell-specific and tumor vasculature-specific ligands potentiates therapeutic efficacy. Cancer Res 66:10073–10082
Pinho STP, Freedman HI, Nani F (2002) A chemotherapy model for the treatment of cancer with metastasis. Math Comput Model 36:773–803
Van der Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324:1029–1033
Warburg O (1956) On the origin of cancer cells. Science 123:309–314
Acknowledgments
This work was supported by the Spanish Ministry of Economy and Competitivity under Project Number FIS2013-40653-P.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
López, Á.G., Seoane, J.M. & Sanjuán, M.A.F. A Validated Mathematical Model of Tumor Growth Including Tumor–Host Interaction, Cell-Mediated Immune Response and Chemotherapy. Bull Math Biol 76, 2884–2906 (2014). https://doi.org/10.1007/s11538-014-0037-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11538-014-0037-5